ProPhase Labs to Present at the NobleCon17 Annual Small & Microcap Investor Conference on Tuesday, January 19, 2021 at 12:45 p.m. Eastern Time
11 janv. 2021 08h30 HE
|
ProPhase Labs, Inc.
Company Exceeding Near Term Goals & Expands 2021 Testing Capacity Surpasses Targeted $30 Net Profit Margin Per COVID-19 Test GARDEN CITY, NY, Jan. 11, 2021 (GLOBE NEWSWIRE) -- ProPhase...
ProPhase Labs Announces $5.5 Million Registered Direct Offering of Common Stock and Warrants
05 janv. 2021 12h10 HE
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Jan. 05, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced that it has entered into a definitive...
ProPhase Labs Expands COVID-19 Testing Capacity with New 25,000 Square Feet Testing Facility in Garden City, New York
08 déc. 2020 16h15 HE
|
ProPhase Labs, Inc.
Company Expands to Meet Anticipated Demand for Increased Molecular Testing From New Business Opportunities – Aiming For Capacity to Process 50,000 Tests per Day Doylestown, PA, Dec. 08, 2020 (GLOBE...
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2020
16 nov. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 16, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, today announced net sales of $3.8 million for...
ProPhase Labs to Present at the Virtual Fall Investor Summit on Monday, November 16, 2020 at 2:30 p.m. Eastern Time
10 nov. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, PA , Nov. 10, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase Labs”), a diversified medical science and technology company, today announced that management will...
ProPhase Labs Completes Acquisition of CLIA Accredited Lab and Provides Corporate Update
02 nov. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Nov. 02, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has completed the...
ProPhase Labs Announces Definitive Agreement to Acquire CLIA Accredited Lab Certified for COVID-19 and Upper Respiratory Testing
23 oct. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Oct. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today a definitive agreement to...
ProPhase Labs Engages Industry Expert to Advise on Possible Acquisition of CLIA Accredited Labs Certified for COVID-19 and Other Testing
30 sept. 2020 17h04 HE
|
ProPhase Labs, Inc.
Company Enters into Consulting Agreement and Amended and Restated Promissory Note and Security Agreement with Predictive Laboratories, Inc. to Further These Plans DOYLESTOWN, Pennsylvania, Sept. 30,...
ProPhase Labs Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communication Program
30 sept. 2020 08h30 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 30, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, has engaged international investor relations...
ProPhase Labs Announces At-The-Market Equity Facility
23 sept. 2020 16h10 HE
|
ProPhase Labs, Inc.
DOYLESTOWN, Pennsylvania, Sept. 23, 2020 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH, www.ProPhaseLabs.com) today announced that it has entered into an at-the-market (“ATM”) equity...